Baxter International

M&A Science Hosts Modern M&A Virtual Summit

Thursday, October 14, 2021 - 1:32pm

Send outdated M&A practices to the grave with Kison Patel , host of the M&A Science podcast, at the Modern M&A Virtual Summit this October 27, 2021 from 10am to 5pm EST.

Key Points: 
  • Send outdated M&A practices to the grave with Kison Patel , host of the M&A Science podcast, at the Modern M&A Virtual Summit this October 27, 2021 from 10am to 5pm EST.
  • M&A Science , hosted by Kison Patel, is an educational podcast exploring the intricate world of M&A with industry leaders and practitioners.
  • More recently, Kison has expanded the M&A Science umbrella to include a training academy in an effort to share practitioners' most valuable lessons learned.
  • M&A Science Academy is an outcome-based online workshop program, providing clear and tangible value.

Baxter to Present at Credit Suisse 30th Annual Virtual Healthcare Conference

Wednesday, October 13, 2021 - 9:15pm

Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Credit Suisse 30th Annual Virtual Healthcare Conference on Monday, November 8, 2021.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Credit Suisse 30th Annual Virtual Healthcare Conference on Monday, November 8, 2021.
  • Jay Saccaro, Baxters chief financial officer, is scheduled to present at 8:50 a.m. Eastern Time.
  • The live webcast of Baxters presentation can be accessed at www.baxter.com and will be available for replay through November 7, 2022.
  • Every day, millions of patients and caregivers rely on Baxters leading portfolio of critical care, nutrition, renal, hospital and surgical products.

BioLife Plasma Services Announces Expansion of Plasma Donation Centers into Massachusetts

Wednesday, October 13, 2021 - 1:00pm

The Massachusetts centers join a growing network of more than 160 state-of-the-art plasma donation centers in the U.S., recognized for an industry leading donation experience.

Key Points: 
  • The Massachusetts centers join a growing network of more than 160 state-of-the-art plasma donation centers in the U.S., recognized for an industry leading donation experience.
  • BioLife is also evaluating additional Massachusetts locations to continue its expansion in the state in the future.
  • To learn more about BioLife Plasma Services, the donation process, and to schedule an appointment, please visit the BioLife website.
  • BioLife Plasma Services is an industry leader in the collection of high-quality plasma that is processed into life-saving plasma-based therapies.

Johnson & Johnson Announces Jessica Moore as Vice President of Investor Relations

Tuesday, October 12, 2021 - 9:15pm

NEW BRUNSWICK, N.J., Oct. 12, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced the appointment of Jessica Moore to Vice President of Investor Relations for Johnson & Johnson, effective November 1, 2021.

Key Points: 
  • NEW BRUNSWICK, N.J., Oct. 12, 2021 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced the appointment of Jessica Moore to Vice President of Investor Relations for Johnson & Johnson, effective November 1, 2021.
  • Ms. Moore will report to Mr. Joseph Wolk, Executive Vice President and Chief Financial Officer of the Company.
  • Ms. Moore brings 20 years of strong, diverse and international financial experience spanning across Sales Operations, Corporate and Regional positions.
  • At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress.

Closed System Transfer Devices (Membrane-to-Membrane, Needleless) Market - Global Forecast to 2026 - ResearchAndMarkets.com

Tuesday, October 12, 2021 - 5:52pm

The closed system transfer devices (CSTDs) market is projected to reach USD 2,002 million by 2026 from USD 814 million in 2021, at a CAGR of 19.7%.

Key Points: 
  • The closed system transfer devices (CSTDs) market is projected to reach USD 2,002 million by 2026 from USD 814 million in 2021, at a CAGR of 19.7%.
  • The diaphragm-based devices segment accounted for the largest share of the closed system transfer devices market in 2020.
  • The vial access devices segment accounted for the largest share of the closed system transfer devices market in 2020.
  • Major players in the closed system transfer devices market include Becton, Dickinson and Company (US), ICU Medical (US), Equashield.

Solarea Bio rounds out management team to gear up for commercialization of first product

Thursday, October 7, 2021 - 3:17pm

Through combining expertise in microbial discovery and access to genomic sequencing through the Illumina Accelerator, Solarea was able to prove that hypothesis.

Key Points: 
  • Through combining expertise in microbial discovery and access to genomic sequencing through the Illumina Accelerator, Solarea was able to prove that hypothesis.
  • In addition to their clinical stage product for osteoporosis, Solarea has expanded their focus and has developed a pipeline of products targeting different inflammatory conditions.
  • Solarea Bio raised a Series A round in 2020 and is focusing on expanding their platform and ramping up to commercialize their first product.
  • About Solarea: Solarea Bio is a biotechnology company based in Cambridge, MA developing new microbiome-based solutions to address some of the world's largest health problems.

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates HRC, EBMT, MSON, NLOK; Shareholders are Encouraged to Contact the Firm

Wednesday, October 6, 2021 - 1:32pm

If you are a Hill-Rom shareholder, click here to learn more about your rights and options .

Key Points: 
  • If you are a Hill-Rom shareholder, click here to learn more about your rights and options .
  • Halper Sadeh LLP may seek increased consideration, additional disclosures and information concerning the proposed transaction, or other relief and benefits on behalf of shareholders.
  • Shareholders are encouraged to contact the firm free of charge to discuss their legal rights and options.
  • Halper Sadeh LLP represents investors all over the world who have fallen victim to securities fraud and corporate misconduct.

Global Biosurgery Market (2021 to 2028) - Development of Policies for Reimbursement and Compensation Presents Opportunities - ResearchAndMarkets.com

Tuesday, October 5, 2021 - 4:50pm

Hence, technological advancements, in addition to the rising geriatric population, are estimated to widen the scope and growth of the biosurgery market over the coming years.

Key Points: 
  • Hence, technological advancements, in addition to the rising geriatric population, are estimated to widen the scope and growth of the biosurgery market over the coming years.
  • However, the high cost of surgeries, coupled with complications relating to immune response, are significant factors that weigh down the progression of the biosurgery market globally.
  • The global biosurgery market covers North America, Latin America, Asia-Pacific, Europe, and the Middle East and Africa regions.
  • Globally, the Asia-Pacific is estimated to become the fastest-growing region in the biosurgery market over the forecast period.

Baxter Presents Critical Care Data at 34th Annual European Society of Intensive Care Medicine LIVES Congress

Tuesday, October 5, 2021 - 1:00pm

Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced the presentation of data from three critical care studies at the 34th Annual European Society of Intensive Care Medicine (ESICM) LIVES virtual congress taking place Oct. 3 Oct. 6, 2021.

Key Points: 
  • Baxter International Inc. (NYSE:BAX), a global leader in acute care, announced the presentation of data from three critical care studies at the 34th Annual European Society of Intensive Care Medicine (ESICM) LIVES virtual congress taking place Oct. 3 Oct. 6, 2021.
  • Every day, millions of patients and caregivers rely on Baxters leading portfolio of critical care, nutrition, renal, hospital and surgical products.
  • For 90 years, weve been operating at the critical intersection where innovations that save and sustain lives meet the healthcare providers that make it happen.
  • Baxter and Starling are registered trademarks of Baxter International Inc.
    View source version on businesswire.com: https://www.businesswire.com/news/home/20211005005183/en/

BioLife Solutions Leverages Expanded Bioproduction Tools and Services Portfolio in Multipoint Engagement with Leading CAR T-Cell Developer

Monday, October 4, 2021 - 1:00pm

To date, BioLife'sCryoStorfreeze media is exclusively used in the manufacturingprocess of every dose of the following approved biologic therapies.

Key Points: 
  • To date, BioLife'sCryoStorfreeze media is exclusively used in the manufacturingprocess of every dose of the following approved biologic therapies.
  • BioLife Solutions is a leading supplier of cell and gene therapy bioproduction products and services.
  • For more information, please visit www.biolifesolutions.com , www.scisafe.com , www.stirlingultracold.com , and www.sextonbio.com ,and follow BioLife on Twitter .
  • All statements other than statements of historical fact are statements that could be deemed forward-looking statements.